Features

• The Comprehensive Human Papillomavirus (HPV) Control Panel is intended for use as non-viable, external, positive control material to evaluate the performance of nucleic acid amplification testing (NAAT) procedures
• The Comprehensive Human Papillomavirus (HPV) Control Panel consists of 18 individually packaged lyophilized pellets: six pellets of positive control 1, six pellets of positive control 2, and six pellets of positive control 3
• Positive Control 1: HPV Type 31 Surrogate, gene target E6/E7, HPV Type 31 Surrogate, gene target L1, HPV Type 33 Surrogate, gene target E6/E7, HPV Type 66 Surrogate, gene target E6/E7, HPV Type 68 Surrogate, gene target E6/E7, HPV Type 68 Surrogate, gene target L1, Human Cells
• Positive Control 2: HPV Type 16 Surrogate, gene target E6/E7, HPV Type 16 Surrogate, gene target L1, HPV Type 18 Surrogate, gene target E6/E7, HPV Type 18 Surrogate, gene target L1, HPV Type 35 Surrogate, gene target E6/E7, HPV Type 45 Surrogate, gene target E6/E7, HPV Type 45 Surrogate, gene target L1, HPV Type 59 Surrogate, gene target E6/E7, Human Cells
• Postive Control 3: HPV Type 39 Surrogate, gene target E6/E7, HPV Type 51 Surrogate, gene target E6/E7, HPV Type 52 Surrogate, gene target E6/E7, HPV Type 56 Surrogate, gene target E6/E7, HPV Type 58 Surrogate, gene target E6/E7, Human Cells

Product Specifications